CONSHOHOCKEN, PA — The GBS | CIDP Foundation International has unveiled ... GBS is a rare disorder in which the body’s immune system attacks the peripheral nervous system, leading to symptoms ...

Myelin seems to be the primary target of the immune attack in these disorders ... (EAN), which resembles GBS, and describe four clinical syndromes in detail: GBS, CIDP, MMN, and nonsystemic ...

Guillain-Barre Syndrome (GBS) is a rare autoimmune disorder in which the body's immune system mistakenly attacks the peripheral nerves, which are responsible for transmitting signals between the ...

Despite GBS's life-altering impact, treatment options today are limited, outdated and often inadequate. Developing more effective therapies for this terrible disease should be an urgent public ...

GBS, a neurological condition triggered by an ... and the YCM Hospital in the nearby Pimpri-Chinchwad city. The disease's arrival in India has caused widespread alertness about the symptoms ...

Feb. 28, 2025 /PRNewswire/ -- The GBS | CIDP Foundation International today ... The report's release coincides with Rare Disease Day, a global initiative to raise awareness and generate support ...

Vyvgart Hytrulo (efgartigimod alfa/hyaluronidase) is the first drug in the FcRn blocker class to treat CIDP, a rare autoimmune disease of the peripheral nervous system that causes fatigue ...

Guillain-Barré Syndrome (GBS) is a rare autoimmune disorder where the immune system attacks peripheral nerves, causing weakness, tingling, and sometimes paralysis. It often follows infections ...